E_DEPRECATED Error in file �functions_general.php� at line 301: Function utf8_encode() is deprecated IGEM Therapeutics - ProfileE_DEPRECATED Error in file �functions_general.php� at line 348: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 301: Function utf8_encode() is deprecated

PharmiNews

Directory of Pharma Companies and News

Company Profile

E_DEPRECATED Error in file �functions_general.php� at line 301: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 357: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 375: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 400: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 317: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 292: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 284: Function utf8_encode() is deprecated E_WARNING Error in file �functions_general.php� at line 287: Trying to access array offset on value of type bool E_DEPRECATED Error in file �functions_general.php� at line 287: trim(): Passing null to parameter #1 ($string) of type string is deprecated E_DEPRECATED Error in file �functions_general.php� at line 348: Function utf8_encode() is deprecated

IGEM Therapeutics

E_DEPRECATED Error in file �functions_general.php� at line 326: Function utf8_encode() is deprecated

IGEM is a UK immuno-oncology company developing novel immunoglobulin E (IgE) antibodies to treat cancer. Unlike immunoglobulin G (IgG), IgE has evolved to kill tissue-dwelling multicellular parasites endowing it with several key features that make it ideal for the treatment of solid tumours.

Pre-clinical proof of concept has been obtained with two different IgE antibodies both showing significantly greater efficacy versus IgG comparators in a variety of rodent cancer models. IGEM is building a portfolio of IgE antibody candidates targeting folate receptor alpha, HER2, EGFR, PD-L1 and CSPG4. The company is also developing a novel antibody platform technology based on protein and glyco-engineering of the epsilon constant region of IgE.

IGEM is a spin out of King’s College London and has access to the world class expertise in the lab of Dr Sophia Karagiannis at KCL.

Keywords:

E_DEPRECATED Error in file �company-code.php� at line 190: Function utf8_encode() is deprecated

0 results